Classifying antipsychotic agents : need for new terminology

CNS Drugs
Ripu D Jindal, Matcheri S Keshavan

Abstract

Converging data from multiple lines of research provide growing understanding of the pharmacological basis of the efficacy and tolerability of antipsychotic agents. This review highlights some of the drawbacks of the current practice of classifying antipsychotic agents into first- and second-generation agents, and argues that much of what is known about an antipsychotic agent in terms of its efficacy and tolerability can be predicted from its binding affinity at different receptors. This makes a case for a new system of classification that reflects the receptor binding affinity profiles of individual antipsychotic agents. In its quest to make a compelling case, the review provides detailed explanations for the pharmacological basis of antipsychotic efficacy, antipsychotic-induced weight gain and diabetes mellitus, cognitive effects and other adverse effects.

References

Dec 25, 2012·CNS Drugs·Mark Sanford
Nov 1, 1988·European Journal of Pharmacology·G E MartinM K Scott
May 4, 2010·Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists·Yu-Wen ChenCheng-Hsing Kao
Jan 2, 2013·Journal of Clinical Psychopharmacology·Irina VasilyevaSilvia Alessi-Severini
Apr 12, 2011·Journal of Pain and Symptom Management·Paul HowardAndrew Wilcock
Aug 12, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chun-Yen ChenChih-Lun Chen
Jun 29, 2011·Perspectives in Psychiatric Care·Debbie SteeleNorman L Keltner
Aug 9, 2017·BMC Complementary and Alternative Medicine·Patrick AmoatengSamuel B Kombian
Jun 30, 2018·The Mental Health Clinician·Allison SchmitzPamela Wolf

Citations

Jan 1, 1996·Neuropharmacology·M JaberM G Caron

Related Concepts

Antipsychotic Effect
Adverse Effects
Synaptic Receptors
Weight Gain
Antipsychotic Agents
Dyskinesia, Medication-Induced
Drug Toxicity
Cognition
Diabetes Mellitus
Receptor Binding

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.